Average Co-Inventor Count = 6.52
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-Farber-Cancer Institute Inc. (7 from 1,216 patents)
2. The General Hospital Corporation (6 from 2,903 patents)
3. Other (1 from 833,002 patents)
4. The University of Texas System (1 from 5,506 patents)
5. The University of North Carolina at Chapel Hill (1 from 1,280 patents)
8 patents:
1. 12006555 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
2. 11009508 - Methods of diagnosing and prognosing lung cancer
3. 10669589 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
4. 10172581 - Methods of assessing tumor growth
5. 10000815 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
6. 9119379 - Systems and methods for detecting estrus
7. 9035036 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
8. 7294468 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments